Practice survey on recent changes in post cardiac arrest care and temperature management in French intensive care units.

BACKGROUND

Recent guidelines for post-cardiac arrest (CA) management have undergone significant changes regarding targeted therapeutic management (TTM), transitioning from hypothermia to temperature control. We aimed to assess changes in post-CA management in French intensive care units following the new recommendations.

METHODS

Two declarative web surveys were conducted from March to August 2023. We compared the doctors' survey to that previously published in 2015. We contacted 389 departments from 276 French centers.

RESULTS

Three hundred thirty-four physicians from 189 distinct ICUs departments participated in the survey. TTM was used by 95.5 % of respondents. TTM with temperature feedback device was used by 64 % of respondents. In multivariate analysis, use of TTM with temperature feedback was associated with university hospital responder [OR 1.99 (1.19-3.34, p = 0.009)], high CA admissions rate [OR 2.25 (1.13-4.78, p = 0.026)], use of a written CA procedure [OR 1.76 (1.07-2.92, p = 0.027)] and presence of a cath-lab performing coronary angiography [OR 2.42 (1.33-4.44, p = 0.004)]. The targeted temperature rose from 32 to 34 °C in 2015, to 35-36 °C in 2023 (p < 0.001). Proportions of TTM with temperature feedback devices switched from 45 % to 65 % (p < 0.001). 660 nurses responses from 150 ICUs were analyzed. According to TTM users, gel-coated water circulating pads and intravascular cooling were considered the most effective devices and were found to be easily adjustable.

CONCLUSIONS

These surveys provide insights into post-resuscitation care and TTM practice in France. One year after their publication, the latest recommendations concerning TTM have not been fully implemented, as the majority of ICUs continue to use moderate hypothermia. They widely reported employing specific TTM, with the use of TTM with temperature feedback devices increasing significantly. Heterogeneity exists regarding the TTM systems used, with a significant proportion lacking temperature feedback. This aspect requires specific attention, depending on local constraints and devices costs.

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest CH, AK, JM, BM declare that they have no competing interests. BL received fees and grant from AOP Pharma, Orion, BD. ND traveled and received meeting fees from Bard (Beckton Dickinson) and Zoll.